ClinicalTrials.gg
CompletedNCT07801053Updated Sep 3, 2026

Suspension Exercises vs Conventional Physiotherapy for Chronic Low Back Pain

An interventional study of Suspension Exercises Using the Redcord® Neurac Method and Conventional Physiotherapy in Treatment Adherence, sponsored by Lebanese German University. Completed at 1 site in Lebanon. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Lebanese German University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2026, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
25 Years to 60 Years
Sex
All
01

Study summary

This study compared the effectiveness of suspension exercises based on the Neurac method with conventional physiotherapy in adults with chronic non-specific low back pain. The study evaluated changes in pain intensity, health-related quality of life, and functional performance following a six-week intervention.

02

Conditions studied

  • Treatment Adherence
03

In context

Treatment Adherence and Compliance

353 studies on the registry are indexed under Treatment Adherence and Compliance; 109 are open to participants now.

This study's enrollment of 80 is close to the median of 83 across 273 interventional studies indexed under Treatment Adherence and Compliance.

Browse Treatment Adherence and Compliance studies →

Lead sponsor

Lebanese German University is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Adults aged 25 to 60 years with chronic non-specific low back pain.

    2. No history of previous spinal surgery.

    3. No history of major lumbar trauma.

    4. Pain intensity of ≥3/10 on the Visual Analogue Scale (VAS).

    5. Ability to understand the instructions and complete the questionnaires.

    6. No previous participation in a suspension exercise program

Exclusion criteria

Exclusion Criteria:

  1. Recent lumbar trauma.
  2. Spinal surgery performed less than six months before enrollment.
  3. Pregnancy.
  4. Severe cognitive or psychological disorders.
  5. Refusal to participate.
  6. Severe cardiovascular complications.
  7. Acute joint pain limiting the ability to perform the exercises.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Suspension Exercise Group

    Participants received a standardized suspension exercise program based on the Redcord® Neurac method. The intervention consisted of 12 supervised treatment sessions delivered over a period of 6 weeks.

    Behavioral: Suspension Exercises Using the Redcord® Neurac Method

  • Active comparator
    Conventional Physiotherapy Group

    Participants received a standardized conventional physiotherapy program consisting of thermotherapy, transcutaneous electrical nerve stimulation (TENS), manual therapy, therapeutic exercises, and a home exercise program. The intervention consisted of 12 supervised treatment sessions delivered over a period of 6 weeks.

    Behavioral: Conventional Physiotherapy

Interventions

  • BehavioralSuspension Exercises Using the Redcord® Neurac Method

    A standardized suspension exercise program based on the Redcord® Neurac method, consisting of 12 supervised treatment sessions over 6 weeks.

  • BehavioralConventional Physiotherapy

    A standardized conventional physiotherapy program consisting of thermotherapy, transcutaneous electrical nerve stimulation (TENS), manual therapy, therapeutic exercises, and a home exercise program, delivered in 12 supervised treatment sessions over 6 weeks.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity Measured by the Visual Analogue Scale (VAS)

    Pain intensity was assessed using the Visual Analogue Scale (VAS). Change in pain intensity was evaluated by comparing the VAS score before and after the six-week intervention.

    Time frame: Baseline and immediately after the 6-week intervention

Secondary outcomes

  1. Change in Health-Related Quality of Life Measured by the Short Form-36 (SF-36)

    Health-related quality of life was assessed using the Short Form-36 (SF-36) questionnaire. Change in SF-36 scores was evaluated by comparing measurements obtained before and after the six-week intervention.

    Time frame: Baseline and immediately after the 6-week intervention

  2. Change in Functional Performance Assessed by the Neurac Test Procedure

    Functional performance was assessed using the Neurac test procedure. Change in functional performance was evaluated by comparing measurements obtained before and after the six-week intervention.

    Time frame: Baseline and immediately after the 6-week intervention

07

Study locations

1 site
  • Motiongate clinic
    Jounieh, Lebanon
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Jun 2026, 5 months.

Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's 5 months is below that.

Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 28, 2026
First posted
Sep 3, 2026
StartActual
Jan 15, 2026
Primary completionActual
Jun 26, 2026
CompletionActual
Aug 26, 2026
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07801053
Lead sponsor
Lebanese German University
Responsible party
Marie-Louise Ayoub (Dr, Lebanese German University) — Principal investigator
First posted
Sep 3, 2026
Start date
Jan 15, 2026
Primary completion
Jun 26, 2026
Completion
Aug 26, 2026
Last update
Sep 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion